MRC1 and pachyonychia congenita: The revised Bethesda Guidelines (RBG) for identifying MMR gene mutation carriers categorize PC as one of the LS-associated neoplasms, along with other types of malignancies such as endometrial, small intestinal or ureter/renal pelvic cancers [31].